EGFR and non-small cell lung carcinoma: Another study reported that the standard treatment for multiple BM, whole-brain radiotherapy, could be delayed by the administration of upfront EGFR-TKIs for NSCLC patients with BM, thereby reducing the toxic effect of radiotherapy and improving quality of life for such patients [18].